Profile data is unavailable for this security.
About the company
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.
- Revenue in CNY (TTM)2.19bn
- Net income in CNY50.41m
- Incorporated1992
- Employees1.43k
- LocationShanghai Shenqi Pharmaceutical Investment Management Co LtdRoom 613Changfa Tower, No. 128, Weihai RoadSHANGHAI 200003ChinaCHN
- Phone+86 2 153750009
- Fax+86 2 153750010
- Websitehttp://www.gzsq.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 211.45m | 3.70bn | 1.16k | 17.49 | 1.96 | -- | 2.56 | 2.25 | 2.25 | 15.42 | 20.06 | 0.6426 | 1.49 | 9.74 | 1,244,707.00 | 8.34 | 11.21 | 9.79 | 14.05 | 61.32 | 69.00 | 12.98 | 13.96 | 3.18 | -- | 0.0566 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
| Beijing Konruns Pharmaceutical Co Ltd | 846.29m | 114.79m | 3.80bn | 447.00 | 32.48 | 1.19 | -- | 4.49 | 0.7311 | 0.7311 | 5.38 | 20.03 | 0.2178 | 1.95 | 2.90 | 1,893,258.00 | 3.81 | 5.43 | 4.48 | 6.24 | 87.83 | 89.93 | 17.52 | 20.76 | 3.36 | -- | 0.0582 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
| Jiangsu Aidea Pharmaceutical Co Ltd | 408.68m | -104.55m | 3.88bn | 476.00 | -- | 3.62 | -- | 9.48 | -0.2384 | -0.2384 | 0.9459 | 2.54 | 0.2193 | 0.9553 | 2.66 | 858,576.30 | -5.65 | -2.40 | -8.32 | -2.85 | 48.96 | 39.00 | -25.77 | -10.15 | 1.11 | -- | 0.3018 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
| Shanghai Fudan Forward S&T Co Ltd | 638.98m | -15.28m | 3.91bn | 1.36k | -- | 5.06 | -- | 6.12 | -0.0222 | -0.0222 | 0.9345 | 1.13 | 0.3799 | 0.6476 | 8.53 | 468,807.20 | -0.9863 | -0.8781 | -1.68 | -1.53 | 36.63 | 43.22 | -2.60 | -1.85 | 0.413 | -2.40 | 0.3319 | -- | -13.86 | -7.58 | 196.17 | -32.57 | -13.88 | -- |
| Shanghai Shenqi Pharmactcl Inv Mgt CoLtd | 2.19bn | 50.41m | 3.91bn | 1.43k | 81.27 | 1.74 | -- | 1.78 | 0.0944 | 0.0944 | 4.11 | 4.41 | 0.6831 | 4.89 | 5.41 | 1,538,342.00 | 1.61 | -0.6002 | 2.02 | -0.7417 | 46.46 | 56.64 | 2.35 | -0.9128 | 2.46 | 23.86 | 0.0908 | -- | -2.00 | 4.79 | 17.41 | -11.68 | -25.97 | -- |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.37bn | 13.89m | 4.02bn | 1.85k | 182.40 | 1.51 | -- | 1.69 | 0.0502 | 0.0502 | 5.72 | 6.08 | 0.4094 | 1.74 | 6.76 | 1,284,337.00 | 0.2471 | 3.30 | 0.4806 | 5.97 | 21.35 | 32.35 | 0.6036 | 8.21 | 0.4855 | 1.21 | 0.4994 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
Data as of Nov 05 2024. Currency figures normalised to Shanghai Shenqi Pharmaceutical Investment Management Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 134.90k | 0.03% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 101.00k | 0.02% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 97.60k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 26.90k | 0.01% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 22.30k | 0.01% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2024 | 21.00k | 0.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 7.50k | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 5.90k | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 4.40k | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 2.00k | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
